MyFinsight
Home
Blog
About
Contact
Proceeds from debt
$17,000,000
Proceeds from the sale of
common stock and...
$6,898,857
Net cash provided by
financing activities
$6,898,857
Canceled cashflow
$17,000,000
Net decrease in cash
and cash...
-$929,198
Canceled cashflow
$6,898,857
Accounts payable
$5,706,232
Accrued expenses
$4,387,442
Stock-based compensation
$757,484
Inventory
-$113,822
Loss on equity method
investment
-$45,119
Amortization
$30,417
Repayment of debt
$17,000,000
Net cash used in
operating activities
-$7,828,055
Canceled cashflow
$11,040,516
Gain from change in
fair value of warrant...
-$6,838,022
Net (loss) income
-$4,453,081
Accounts receivable
$2,605,219
Loss from change in
fair value of...
-$2,495,400
Prepaid expenses and
other current assets
$2,176,011
Gain on
extinguishment of debt
$285,600
Operating lease
liabilities
-$15,238
Back
Back
Cash Flow
Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc. (OTLK)
source: myfinsight.com